Skip to main content

Main menu

  • Home
  • Articles
    • Current Issue
    • Next in The JI
    • Archive
    • Brief Reviews
    • Pillars of Immunology
    • Translating Immunology
    • Most Read
    • Top Downloads
    • Annual Meeting Abstracts
  • COVID-19/SARS/MERS Articles
  • Info
    • About the Journal
    • For Authors
    • Journal Policies
    • Influence Statement
    • For Advertisers
  • Editors
  • Submit
    • Submit a Manuscript
    • Instructions for Authors
    • Journal Policies
  • Subscribe
    • Journal Subscriptions
    • Email Alerts
    • RSS Feeds
    • ImmunoCasts
  • More
    • Most Read
    • Most Cited
    • ImmunoCasts
    • AAI Disclaimer
    • Feedback
    • Help
    • Accessibility Statement
  • Other Publications
    • American Association of Immunologists
    • ImmunoHorizons

User menu

  • Subscribe
  • Log in

Search

  • Advanced search
The Journal of Immunology
  • Other Publications
    • American Association of Immunologists
    • ImmunoHorizons
  • Subscribe
  • Log in
The Journal of Immunology

Advanced Search

  • Home
  • Articles
    • Current Issue
    • Next in The JI
    • Archive
    • Brief Reviews
    • Pillars of Immunology
    • Translating Immunology
    • Most Read
    • Top Downloads
    • Annual Meeting Abstracts
  • COVID-19/SARS/MERS Articles
  • Info
    • About the Journal
    • For Authors
    • Journal Policies
    • Influence Statement
    • For Advertisers
  • Editors
  • Submit
    • Submit a Manuscript
    • Instructions for Authors
    • Journal Policies
  • Subscribe
    • Journal Subscriptions
    • Email Alerts
    • RSS Feeds
    • ImmunoCasts
  • More
    • Most Read
    • Most Cited
    • ImmunoCasts
    • AAI Disclaimer
    • Feedback
    • Help
    • Accessibility Statement
  • Follow The Journal of Immunology on Twitter
  • Follow The Journal of Immunology on RSS

Antigenic competition affects the magnitude and breadth of CD8 T cell immunity following immunization with a nanoparticle neoantigen cancer vaccine

Nicolas J Blobel, Andrei Ramirez-Valdez, Andrew S Ishizuka, Geoffrey M Lynn and Robert A Seder
J Immunol May 1, 2017, 198 (1 Supplement) 73.20;
Nicolas J Blobel
1Vaccine Research Center, NIAID, NIH
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Andrei Ramirez-Valdez
1Vaccine Research Center, NIAID, NIH
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Andrew S Ishizuka
1Vaccine Research Center, NIAID, NIH
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Geoffrey M Lynn
2Avidea Technologies
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Robert A Seder
1Vaccine Research Center, NIAID, NIH
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Info & Metrics
Loading

Article Information

vol. 198 no. 1 Supplement 73.20

Published By 
The American Association of Immunologists, Inc.
Print ISSN 
0022-1767
Online ISSN 
1550-6606
History 
  • Published online June 13, 2017.

Copyright & Usage 
Copyright © 2017 by The American Association of Immunologists, Inc.

Author Information

  1. Nicolas J Blobel1,
  2. Andrei Ramirez-Valdez1,
  3. Andrew S Ishizuka1,
  4. Geoffrey M Lynn2 and
  5. Robert A Seder1
  1. 1Vaccine Research Center, NIAID, NIH
  2. 2Avidea Technologies

Article usage

Article usage: June 2017 to December 2020

AbstractFullPdf
Jun 20177700
Jul 20174000
Aug 20175200
Sep 20175700
Oct 20173300
Nov 20172600
Dec 20173900
Total 201732400
Jan 20182600
Feb 20181700
Mar 20183000
Apr 20182700
May 20183700
Jun 20182500
Jul 20183100
Aug 20181200
Sep 20181700
Oct 20183200
Nov 20182400
Dec 20181600
Total 201829400
Jan 20191400
Feb 20192300
Mar 20191000
Apr 20191800
May 20192500
Jun 20191400
Jul 20191900
Aug 2019400
Sep 2019700
Oct 20191100
Nov 20192200
Dec 20191000
Total 201917700
Jan 20201900
Feb 20204900
Mar 20203500
Apr 20203100
May 2020400
Jun 2020900
Jul 20201000
Aug 2020200
Sep 20201100
Oct 20201402
Nov 20201300
Dec 2020800
Total 202020502
Total100002

Previous
Back to top

In this issue

The Journal of Immunology
Vol. 198, Issue 1 Supplement
1 May 2017
  • Table of Contents
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word about The Journal of Immunology.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Antigenic competition affects the magnitude and breadth of CD8 T cell immunity following immunization with a nanoparticle neoantigen cancer vaccine
(Your Name) has forwarded a page to you from The Journal of Immunology
(Your Name) thought you would like to see this page from the The Journal of Immunology web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
Antigenic competition affects the magnitude and breadth of CD8 T cell immunity following immunization with a nanoparticle neoantigen cancer vaccine
Nicolas J Blobel, Andrei Ramirez-Valdez, Andrew S Ishizuka, Geoffrey M Lynn, Robert A Seder
The Journal of Immunology May 1, 2017, 198 (1 Supplement) 73.20;

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
Antigenic competition affects the magnitude and breadth of CD8 T cell immunity following immunization with a nanoparticle neoantigen cancer vaccine
Nicolas J Blobel, Andrei Ramirez-Valdez, Andrew S Ishizuka, Geoffrey M Lynn, Robert A Seder
The Journal of Immunology May 1, 2017, 198 (1 Supplement) 73.20;
del.icio.us logo Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like

Jump to section

  • Article
  • Info & Metrics

Related Articles

Cited By...

More in this TOC Section

  • Role of necroptotic cancer cells in anti-cancer immunity
  • Inducing Immunological Tolerance with Synthetic Nanoparticles
  • TLR8/7 combined withTLR3 or TLR4 enhances DC-NK driven effector T cells
Show more Late-Breaking Vaccines and Immunotherapy

Similar Articles

Navigate

  • Home
  • Current Issue
  • Next in The JI
  • Archive
  • Brief Reviews
  • Pillars of Immunology
  • Translating Immunology

For Authors

  • Submit a Manuscript
  • Instructions for Authors
  • About the Journal
  • Journal Policies
  • Editors

General Information

  • Advertisers
  • Subscribers
  • Rights and Permissions
  • Accessibility Statement
  • Public Access
  • Privacy Policy
  • Disclaimer

Journal Services

  • Email Alerts
  • RSS Feeds
  • ImmunoCasts
  • Twitter

Copyright © 2021 by The American Association of Immunologists, Inc.

Print ISSN 0022-1767        Online ISSN 1550-6606